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Background: The intense pain and anxiety triggered by burns and their associated wound care procedures are
well established in the literature. Non-pharmacological intervention is a critical component of total pain
management protocols and is used as an adjunct to pharmacological analgesia. An example is virtual reality, which
has been used effectively to dampen pain intensity and unpleasantness. Possible links or causal relationships
between pain/anxiety/stress and burn wound healing have previously not been investigated. The purpose of this
study is to investigate these relationships, specifically by determining if a newly developed multi-modal procedural
preparation and distraction device (Ditto™) used during acute burn wound care procedures will reduce the pain
and anxiety of a child and increase the rate of re-epithelialization.
Methods/design: Children (4 to 12 years) with acute burn injuries presenting for their first dressing change will be
randomly assigned to either the (1) Control group (standard distraction) or (2) Ditto™ intervention group (receiving
Ditto™, procedural preparation and Ditto™ distraction). It is intended that a minimum of 29 participants will be
recruited for each treatment group. Repeated measures of pain intensity, anxiety, stress and healing will be taken at
every dressing change until complete wound re-epithelialization. Further data collection will aid in determining
patient satisfaction and cost effectiveness of the Ditto™ intervention, as well as its effect on speed of wound
re-epithelialization.
Discussion: Results of this study will provide data on whether the disease process can be altered by reducing
stress, pain and anxiety in the context of acute burn wounds.
Trial registration: ACTRN12611000913976
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Burn pain
Pain is multidimensional and highly complex, and
involves the integration of sensation and perception.
Emotions, individual attributes, cognitive, environmental
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reproduction in any medium, provided the orattention and level of control, all play a significant role
in diminishing or magnifying the perception of pain
[1,2]. Despite considerable advances in burn wound
management, procedural pain is both the most intense
pain, and the most common type of burn pain to be
undertreated [3]. Lack of well-established evidence-
based protocols of burn pain management; inaccurate
fears of addiction; infrequent pain assessment; and poor
correlations between the nurse’s and the patient’s per-
ception of pain, attribute to the occurrence of under
medication in children [4]. It is not surprising that theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stress and anxiety, particularly for children.
Procedural anxiety
Anxiety, which commonly co-exists with pain, impedes
our coping mechanisms and ability to tolerate pain.
Anxiety is a future-orientated emotion of apprehension,
nervousness, tension, fear and worry, accompanying
physical sensations and influencing subjective perception
[5]. Highly anxious burn patients are, therefore, more
susceptible to lower pain tolerance [6,7]. Several studies
refer to the reciprocal relationship between pain and
anxiety [8,9]. In addition to anxiety, burn injuries, which
are a type of trauma, may induce acute stress symptoms,
[10] and psychological disorders, including post-
traumatic stress disorder (PTSD) [11].
The effect of stress on the body
Pain and anxiety places the body under both physical
and physiological stress. Stress has been reported to
interrupt and delay the cascade of healing in several
studies, including skin barrier recovery after tape strip-
ping [12,13]; punch wound biopsies [14-16]; suction
induced blisters [17,18] and pre-surgical stress [19]. The
biological mechanisms behind this may be explained
through the stress induced elevation of glucocorticoids
and adrenaline and noradrenaline levels. Elevation of
these stress hormones produces an immunosuppressive
effect, reducing the infiltration and activation of neutro-
phils and macrophages [20], and also suppressing the
production of proinflammatory cytokines IL-1β and
TNF-α [21]. Proinflammatory cytokines are crucial to
the recruitment of phagocytic cells to clear away con-
taminating debris; in activating and recruiting cells
involved in wound healing, including lymphocytes and
other macrophages; and regulating fibroblast chemo-
taxis, proliferation, collagen synthesis and endothelial
cells involved in the repair process [22]. Attenuation of
the expression of these proinflammatory cytokines is
likely to impair healing through delaying the inflamma-
tory stage of wound healing [23].
Additionally, immune function plays a pivotal role,
particularly in the early processes of wound healing. Ele-
vated glucocorticoids, adrenaline and noradrenaline alter
cellular function and differentiation of T cells, causing a
shift from Th1 cellular to Th2 humoral immune func-
tion [24]. Stress-induced suppression of Th1 cellular im-
munity may inhibit the secretion of inducible nitric
oxide synthase (iNOS) in macrophages [22]. Angiogen-
esis, endothelial and epithelial cell proliferation and mi-
gration are central to wound healing and are highly
influenced by nitric oxide [25]. Additionally, an increase
in iNOS production has been shown to be just as detri-
mental as iNOS deficiency [26]. Stress-induced increasesof adrenaline in mice were shown to heighten iNOS to
cytotoxic levels, impairing wound healing [20]. A stress–
induced shift to Th2 humoral immunity activates mast
cells, which release histamine and result in inflamma-
tion. The Th2 profile up-regulates B lymphocytes, lead-
ing to the production of antibodies [27], rather than
contributing to wound healing processes. Stress may still
continue to disrupt healing after wound closure. Fibro-
blasts, together with their by-products collagen and
matrix metalloprotinases (MMPs), comprise the main
contributors to wound maturation [28]. Stressed mice
displayed reduced levels of matrix MMP-2 and MMP-9,
which are involved in cell migration and collagen turn-
over. Consequently, reduced levels may delay granula-
tion tissue re-modeling, resulting in a less organized
collagen structure (rather than being aligned parallel
with the lines of contraction) and immature collagen
scaffolds [20].
Reducing pain, anxiety and stress
Dampening pain intensity, unpleasantness, anxiety and
time spent thinking about pain through the use of vir-
tual reality (VR), has created much interest since the
first published case report in 1999 with adolescents dur-
ing burn wound care procedures [29]. An accumulation
of studies in the area of burns are reporting a discernible
reduction in pain ratings when VR is used alongside
pharmacological intervention [30-39]. VR encompasses
multisensory stimuli from sight, sound and touch,
greatly drawing the subject's attention into the virtual
world, creating a sense of “presence” [31]. VR acts to
psychologically dissociate the patient from pain by acti-
vating higher cognitive and emotional regions in the
brain. The full extent and awareness of pain is reduced,
as seen in functional magnetic resonance imaging which
showed a dampened transmission to primary regions
involved in emotional processing of pain (caudal anterior
cingulated cortex) and the sensory component of pain
(primary somatosensory cortex) [40]. Distraction has
also been shown to gate pain perception through activa-
tion of the periaqueductal gray, which was not activated
during pain stimulus alone [41].
The multi-modal distraction Ditto™ (Diversionary
Therapy Technologies, Queensland, Australia) is a med-
ical device that has a preparatory and distraction phase
[42]. The preparatory phase involves the child engaging
in the story “Bobby gets a Burn©”. This interactive story
has been specifically tailored for 3- to 12-year-olds to ex-
plain the clinical procedures and sensory phases of a
burn dressing change in a child-focused manner. The
story aims to reduce anxiety, fear and distress through
exposing and desensitizing the child to the procedure; ac-
knowledging feelings associated with the sensory aspects
of the procedure; and instilling a sense of control
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what will transpire. Following the preparatory story,
conducted in the waiting room, the child engages in a
choice of interactive stories or games throughout
wound care procedures, forming the distraction phase
of the Ditto™. A large degree of the success of the
Ditto™ device is due to its novel design [42], and the
unique and child-friendly educational content concern-
ing the procedure [34]. Off-the-shelf virtual reality sys-
tems have not previously been able to significantly
decrease burn pain scores in adolescents [43]. However,
the novel and customized content and technology of the
Ditto™ has proven effective in reducing pain levels com-
pared to off-the-shelf video games [34].Figure 1 Study design flow chart. The sequential order and timing of daResults from Miller’s trials [33,34] confirmed the ef-
fectiveness of the Ditto™ in significantly reducing pain
ratings and treatment length. Retrospective review of
medical notes identified the Ditto™ treatment group
wounds re-epithelialized an average of two days faster
than the standard distraction group [33]. This exciting
and clinically significant finding highlights the potential
of this Ditto™ device with pain reduction and also pos-
sibly improving wound healing. In the Miller trial, burn
wound depth was not matched between control and
treatment arms and the measurement of wound re-
epithelialization was only obtained retrospectively from
the chart notes. The possible link between stress and
burn wound healing have stimulated the development ofta collection within the context of burn wound care procedures.
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pain in a scientific and controlled manner.
Objectives
The aim of this study is to determine whether use of the
Ditto™ device is associated with the rate of burn wound
healing (re-epithelialization).
Methods
Design
This study is a prospective, superiority, randomized con-
trolled trial, consisting of two parallel groups. Participants
will be randomized to receive either (1) standard prepar-
ation and standard distraction (control group), or (2) the
Ditto™ device, including preparation and distraction phases
(treatment group), to test the superiority of this new non-
pharmacological intervention on acute burn wounds. The
data collection design is displayed in Figure 1.
This trial protocol was ethically approved by both the
Queensland Children’s Health Services (Royal Children’s
Hospital) Human Research Ethics Committee and The
University of Queensland Ethics Committee, and was
registered with the Australian New Zealand Clinical
Trials Registry (ACTRN12611000913976).
Setting and participants
Participants are being recruited from the Stuart Pegg
Paediatric Burns Centre at the Royal Children’s Hospital,
Brisbane, Australia. Children presenting to this center
from August 2011 will be screened on admission for
eligibility to this trial.
Inclusion criteria
Participants who are aged between 4 and 13 years with
an acute burn injury of any depth and a burn total body
surface area of <15%, presenting on their first dressing
change, will be considered for inclusion in this study.
Exclusion criteria
Children will be excluded from the study if they are
non-English speaking; have a cognitive, visual or audi-
tory impairment, or a diagnosis under the Autism
Spectrum Disorders; have a diagnosed illness in addition
to a burn injury; have been reported to the Suspected
Child Abuse and Neglect (SCAN) system (as these chil-
dren may have additional emotional and psychological
issues affecting stress, anxiety and coping mechanisms);
receive sedative medication (Midazolam, Entonox™
(BOC Healthcare, Worsley, Manchester, UK)); and if
their burns require grafting. Several of these exclusions
will not become known until after patient recruitment
and randomization due to the nature of the clinic and
the inability to predict patient and wound management
needs prior to dressing removal.All eligible children will be invited to participate. Par-
ticipation in the study will not alter the standard medical
treatment received.
Interventions
Various outcome measures and saliva samples will be
collected at several time points during the burn wound
care procedures (Table 1), with the intervention (Ditto™)
used prior to treatment as preparation and during treat-
ment as a distraction at every change of dressing.
Waiting room
A baseline saliva sample 1 will be obtained in the waiting
room prior to nursing administration of pharmacological
pain relief in accordance with standard practice protocols
within the Burn Centre (primarily oxycodone, an opioid
derived pain medication, dosage determined by body
weight, 0.1 to 0.2 mg/kg). Saliva samples will be collected
with Salivettes™ (Sarstedt Australia Pty, Ltd. Mawson Lakes,
SA, Australia), by placing the synthetic roll in the child’s
mouth for a period of two minutes. Baseline measures will
be taken in the waiting room for: heart rate (HR); oxygen
saturation; pain ratings from the nurse and the child; a self-
report anxiety measure from children eight years and over;
height and weight. Demographic information and pertinent
clinical characteristics will be obtained from the caregiver
and patient chart: mode and site of injury; total body sur-
face area (TBSA) of burn; depth of burn; burn first aid
treatment received; skin color; medication administered;
hours per week spent engaging in computer games and
home video games. TBSA is calculated using the Lund and
Browder chart [44]. Food and fluid consumption two hours
prior to saliva samples will also be recorded as possible
confounding variables of salivary analysis in addition to the
time of sample collection and time of waking.
Participants will then be randomly allocated to one of
two groups:
(a) Treatment Group: Ditto™ device including
preparation and distraction phases.
While waiting for medication to take effect, children
will be given the Ditto™ device in the waiting area to en-
gage in the procedural preparation story of “Bobby gets
a Burn©.” Upon entering the treatment room, partici-
pants will engage in their choice of games or interactive
stories on the Ditto™ device. Engagement will occur
prior to the nurses commencing dressing removal proce-
dures and continue throughout the wound care proced-
ure. Figure 2 depicts a patient engaging in the Ditto™
device during the distraction phase of the treatment.
(b) Control Group: Standard preparation and
distraction
Table 1 Schedule of measurements
Outcome measures Waiting room Pre-DR DR Post-DR Consult New DA Post new DA 3 months post healing
SalivetteW X X X
FLACC X X X X
FPS-R X X X X
VAS-A X X X X
Heart rate X X X X X
Oxygen saturation X X X
Parent demographic questionnaire X
CTSQ (1st COD only) X X
LDI (1st COD only) X
Photos X
Visitrak™ X
Time taken X X X
Dressing used X
Parent satisfaction questionnaire X
Ditto™ Enjoyment Scale X#
The outcome measures taken at each time point over the course of the study.
X = measure taken, # = Ditto™ intervention group only. COD, change of dressing; CTSQ, Children Trauma Screening Questionnaire; DA, dressing application; DR,
dressing removal; FLACC, Faces, Legs, Arms, Cry, Consolability; FPS-R, Faces Pain Scale-Revised; VAS-A, Visual Analog Scale–Anxiety; LDI, laser Doppler image.
Figure 2 Patient engaging in the Ditto™ distraction phase
during dressing removal. A burn patient engaging in Ditto™
distraction as nurses carry out the wound care procedures.
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tion, such as television, videos, books, toys and parental
soothing. Nursing staff may give information before or
during the process as per standard practice; however, no
Ditto™ device procedural preparation or distraction will
be available to the control group.
Dressing removal
Pain, anxiety and physiological measures will be repeated
prior to commencing dressing removal. All participants
will have their HR recorded at two-minute intervals via
an oximeter on their finger or toe. The choice of games/
stories by participants in the treatment group will be
recorded by the primary researcher.
Post dressing removal
Immediately following dressing removal and debride-
ment/wound cleaning, saliva sample 2 will be taken and,
at a further 10 minutes later, saliva sample 3 will be
obtained with date and time of collection documented.
A retrospective measure of pain/distress and anxiety
during the burn dressing removal and debridement will
be taken from the child and nurse. Time taken (in min-
utes) for dressing removal and debridement and the
number of nurses involved will also be recorded.
All participants will then have their burns scanned
using a laser Doppler imager (which measures burn
depth by displaying blood perfusion of tissue) on their
first dressing change only. A Visitrak™ (Smith & Nephew
Pty Limited, London, UK) trace of the wound area and
photos will be taken at every dressing change.
Brown et al. Trials 2012, 13:238 Page 6 of 11
http://www.trialsjournal.com/content/13/1/238New dressing application
The type of new dressing applied will be documented
and HR, oxygen saturations and the number of nurses
and nursing time again recorded for the application of
the new dressing. The choice of Ditto™ distraction games
and stories that the treatment group engaged in will be
recorded.
Post new dressing application
Immediately following the new dressing application,
nursing retrospective pain/distress ratings and child
retrospective pain and anxiety ratings will be taken.
Measures will continue to be taken during every dres-
sing change (usually every three or seven days), using
the same protocol as above until complete re-epitheliali-
zation. Parents will be asked to rate their level of satis-
faction with pain management at the end of every
dressing change with the use of a visual analog scale
from “not satisfied” to “very satisfied.” Children in the
Ditto™ treatment group will be asked to rate their level
of enjoyment in using the Ditto™ on a 10 cm line visual
analog scale. Any relevant comments made by the par-
ticipant or parent/carer will be recorded.
Within the first week the Child Trauma Screening
Questionnaire (CTSQ) will be completed with children
six years and over through interview by the researcher.
The participants will then be reviewed by a consultant
as required.
Follow-up
At the three-month follow-up, the CTSQ will be re-
conducted via mail/phone, and a Salivette™ will be
mailed to participants to obtain sample 4, a true baseline
saliva sample (at a similar time of day to that of the pre-
medication saliva sample 1) and returned via post.
Outcomes
This study will assess the impact of the Ditto™ device on
wound healing of acute burn injuries. Healing will be
measured by the number of days until complete re-
epithelialization, with data collection commencing on
the first dressing change. Secondary outcomes will be
measuring the impact of the Ditto™ device on pain, anxiety
and stress.
Primary outcome measures
Wound healing
The amount of wound re-epithelialization and the num-
ber of days from the date of the burn injury until when
the complete wound re-epithelialization occurs will be
measured by (a) the consultant’s clinical judgment; (b)
blinded review of photographs; and (c) the Visitrak™
(Smith & Nephew) grids. Photos will be taken at every
dressing change with inclusion of a ruler and a grey scale(QPcard 101 v2, Kayell, VIC, Australia). Photograph
lighting levels will be standardized using AdobeW Photo-
shopW Elements 9 (San Jose, CA, USA)) to enable accur-
ate comparison of wound colors across photographs.
Blinded review of photos by a panel of burn wound spe-
cialists to assess re-epithelialization and general wound
appearance will occur upon cessation of data collection.
The Visitrak™ grids will be used to trace around the wet
(un-re-epithelialized) and dry (re-epithelialized) areas of
the wound.
A laser Doppler scan will be performed on the first
dressing change only, following debridement, to accur-
ately measure wound depth, allowing for comparison of
wounds across participants. Burns covering more than
one body part will be scanned separately. In addition,
more than one scan will be performed when burns are
circumferential or extend around curved surfaces in
order to capture accurate frontal, medial and/or lateral
views as appropriate. The MoorLDI2-BI2 laser Doppler
imager (LDI), Moor Instruments Limited, Devon, UK,
contains a visible red laser diode target beam of wave-
length 660 nm, and a near infra-red laser diode for mea-
surements by the laser Doppler with a wavelength of
780 nm. All scans will be performed in burn treatment
rooms maintained at a range of 22 to 24°C. A dark green
sterile surgical drape will be placed as a background
underneath the area to be scanned. The LDI scanner
head will be positioned approximately 35° off perpen-
dicular at a scanning distance range of between 40 and
70 cm from the wound and set on the fast scan reso-
lution setting. The onboard software package (moorBDA
v2.4, Moor Instruments, Axminster, Devon, UK) will be
used to calculate different wound depths (perfusion
units) as a percentage of total wound area.
Secondary outcome measures
Pain
Pain will be assessed before, during and after wound
care procedures by obtaining the participant’s self-report
of pain intensity using the Faces Pain Scale – Revised
(FPS-R); the nurse’s behavioral/observational rating
using the Face, Legs, Arms, Cry, Consolability (FLACC)
scale; and physiological indicators, including heart rate
and oxygen saturations. The Faces Pain Scale – Revised
(FPS-R) was chosen for this study over other pain scales
(for example, the Wong-Baker FACES Pain Scale) due
to its high clinical utility and psychometrically sound
properties [45].
Behavioral measures are an important tool to use as
an adjunct to self-report scales, particularly in children
who may be sedated by drugs; have a cognitive or com-
munication impairment; or are too young to compre-
hend a self-report scale. In addition, a child’s self-report
may be exaggerated, diminished or altered due to
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factors [46]. The Face, Legs, Arms, Cry, Consolability
(FLACC) scale was chosen as it shows excellent respon-
siveness (detecting significant change in pain scores), re-
liability, content and construct validity [46].
Anxiety and fear
Emotional responses encompass negative affect and
emotional facets secondary to pain, including anxiety,
distress and fear. The fear thermometer [47] is an anx-
iety measure that may be used with younger children;
however, it was rejected as a measure as children under
eight years are reported to have difficulty cognitively dis-
tinguishing between the sensory experience of pain (pain
intensity) and the affective response (distress, anxiety,
fear) to pain [48]. An anxiety measure will only be taken
from children eight years and above, using the Visual
Analog Scale-Anxiety (VAS-A). The VAS-A has been
validated as an accurate self-report of anxiety for burn
injuries [49], as well as other patient populations [50-53],
and is more sensitive to change over time for pediatric
studies [54,55].
Stress
Salivary cortisol (reflecting the hypothalamic-pituitary-
adrenal axis activity) and salivary α-amylase (reflecting
sympathetic nervous system activity) will be used as bio-
logical markers of stress levels during burn wound care
procedures. SalivettesW without citric acid (Sarstedt Aus-
tralia Pty. Ltd.) will be used to collect saliva at three time
points: baseline in the waiting room prior to administra-
tion of pain medication; at 0 minutes following dressing
removal and debridement to capture the peak salivary α-
amylase levels; and at 10 minutes to capture the peak
cortisol HPA axis activity. These time points were identi-
fied in a pilot study of 10 patients. At these time points
the absorbent synthetic roll will be placed in the child’s
mouth for a period of two minutes. Date and time of
collection will be recorded and samples will be refri-
gerated at 2°C and processed within seven days. Sam-
ples will be spun in a centrifuge at 3,000 rpm at
room temperature (22°C) for 10 minutes and the saliva
frozen at -80°C until analysis by Queensland Pathology.
Ultra high performance liquid chromatography-tandem
mass spectrometry will be used to analyze salivary cor-
tisol [56] and Amylase EPS-G7 Reagent (Thermo Sci-
entific, Middletown, VA, USA) used to measure salivary
α-amylase, performed according to the manufacturer’s
instructions.
Detection of PTSD in children remains challenging as
the DSM-IV criteria for PTSD has been defined and
tested on adults [57] and shows lack of sensitivity in
diagnosing posttraumatic stress symptoms in young chil-
dren [10]. Screening tools were the only feasible measurefor this study due to clinical utility and the time con-
straints of the setting. The Child Trauma Screening
Questionnaire (CTSQ) [58] is a self-report tool for chil-
dren and adolescents 6 to 16 years, based on the 10-
item Trauma Screening Questionnaire for adults [59].
The CTSQ screens for hyper-arousal symptoms and for
re-experiencing symptoms following the traumatic event
[60]. The CTSQ is more accurate than the Children’s
Impact of Events Scale – version 8 in predicting PTSD
at one month and six months after injury and diagnosing
full and sub-syndromal PTSD [58].
Treatment satisfaction
Engagement, interaction and appropriate use of the
Ditto™ will be measured by participant satisfaction. If a
participant refuses to use the Ditto™ they will be
excluded from the study. If, however, a child accepts the
use of the Ditto™ and appears disinterested and does not
completely engage with the Ditto™, this will be reflected
in the child’s rating of how much they liked using the
Ditto™. Other measurements of engagement were con-
sidered such as video recording, motion monitors meas-
uring limb activation, and frequency measures of time
spent looking away from the device. These latter mea-
sures were unsuitable for the Burn Centre outpatient en-
vironment and contradicted the specific design of the
Ditto™ [42], which enables the child to interact with
their caregiver, receive reassurance or check on the
wound care procedures at any stage.
Indigenous children and children from other ethnici-
ties with darker complexions will be offered the Ditto™
procedural preparation stories with characters that have
darker skin tones. Furthermore, the exposure and fre-
quency of use of other types of video game technologies
will be recorded for each participant and correlated with
Ditto™ satisfaction.
The caregiver is asked to rate their level of satisfaction
with the pain management their child received (from
not satisfied to very satisfied) on a visual analogue scale.
The caregiver is also given the opportunity to comment
on the positive and negative aspects of treatment and
this feedback will remain confidential and will not be
shown to the clinical treating team. Satisfaction with the
Ditto™ during wound care procedures is evaluated by the
child rating how much they liked using the Ditto™ on a
10 cm line sliding scale from enjoyment to disinterest,
depicted by child-friendly images of a smiley face
thumbs up and an unimpressed thumbs down face
anchoring each end of the scale.
Recruitment and withdrawals
Sample size
The standard deviation used in sample size calculations
was based on a previous study by Miller [33], who found
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was four days. Calculations were based on detecting a clin-
ically important difference in time to re-epithelialization
between the control and Ditto groups of three days. With
a power of 80% and significance level of 0.05, a sample size
of 29 participants per group is required.
We expect 10% of eligible participants to dropout be-
fore wound re-epithelialization. We anticipate approxi-
mately 33% of participants recruited would later be
found not to meet the eligibility criteria for the study
due to factors including: the need for grafting; use of
Entonox™; pre-existing anxiety conditions becoming
known; and child protection concerns being raised.
Therefore, it is anticipated that approximately 98 partici-
pants will need to be recruited in total, in order to
achieve final participant numbers of 29 in each group.
Randomization
Participants are randomized using a portable computer-
ized random number generator. Randomization is per-
formed by nursing or administration staff members in
the Burn Centre who are not associated with the study.
The primary researcher is then informed as to which
group the participant has been consigned.
Implementation
Recruitment will take place between 9 August 2011 and
31 August 2012. It is expected the required sample size
will be achieved within this time period. Enrolment of
participants is carried out by the primary researcher.
Children are screened on presentation to the Burn Cen-
ter for eligibility to this prospective randomized con-
trolled trial. Once it has been established that the child
meets all eligibility criteria, the primary researcher
approaches the parent/caregiver/s to explain the study
and provide them with a copy of the study information
sheet. Parent/caregiver/s are encouraged to ask ques-
tions. Parents are guided through the informed consent
form step-by-step to ensure they understand all aspects
of the research project and what participation will
involve.
Blinding
The non-pharmacological intervention received cannot
be masked. Assessment of the primary outcome, re-
epithelialization, is undertaken by burn wound specia-
lists who are masked to treatment received by the
participant.
Discontinuation/adverse events
Dizziness and nausea are potential adverse effects from
engagement in virtual reality. No such effects were
reported in previous studies that used the Ditto™ device
[33,34,61]. If such effects are experienced by participants,they are free to cease participation if desired. All adverse
events will be recorded in both treatment groups.
Statistical methods
Data analysis
All analysis will be conducted using Stata/SE 11 (Stata-
Corp LP, College Station, TX, USA). Analysis will be per-
formed based on the “intention-to-treat” principle,
where participants will be analyzed according to the
treatment they were allocated. Any dropouts will be
excluded from analysis. Participant’s baseline demo-
graphic, clinical and social characteristics will be sum-
marized using descriptive statistics. Between-group
differences at baseline will be investigated using Fisher’s
Exact test (categorical data) or Student’s t-test (continu-
ous data). The association between treatment received
and healing outcomes will be investigated using regres-
sion models. Continuous outcomes will be investigated
using linear regression and binary outcomes with logistic
regression. If assumptions for linear regression are not
met, outcomes will be analyzed using non-parametric
tests. Regression models will include treatment group as
the only main effect, unless groups are significantly
unbalanced at baseline, in which case the regression
models will include two main effects (treatment group
and time) as well as a treatment-by-time interaction
term. The efficacy of the Ditto™ may differ according to
age and the number of days to re-epithelialization will
be affected by the depth of the burn. Analysis will also
be conducted with data stratified for depth of burn
(superficial/superficial partial thickness/deep partial
thickness/full thickness) and age of participant (for ex-
ample, under 7 years 11 months/8 years and greater,
with age strata based on age group validity of the VAS-
A). Where appropriate, repeated-measures analysis will
be undertaken using Generalized Estimating Equations.
Treatment and time will be included as main effects,
and a treatment-by-time interaction will be performed.
For continuous outcomes we will assume a Gaussian
Family and for binary outcomes the Binomial Family,
each with their natural link. An exchangeable correlation
structure will be assumed. For all analyses a P-value of
0.05 will be considered significant. There will be no ad-
justment for multiple comparisons.
Data storage
Data are stored securely by the principal investigator in
locked filing cabinets within the secure area of the
Queensland Children’s Medical Research Institute, The
University of Queensland. Data are entered into an Excel
spread sheet. Incomplete data from medical records are
checked for and identified when entering data into Excel.
All other incomplete data are coded accordingly as miss-
ing, unknown or not applicable. The data set will be
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On completion of the trial, data will be kept for a period
of 15 years in accordance with the ethical requirements
of the Queensland Children’s Health Services (RCH)
Human Research Ethics Committee.
Discussion
This trial utilizes a number of measures to investigate
the links between the novel Ditto™ procedural prepar-
ation and distraction intervention and the patient’s ex-
perience of pain, stress and anxiety, to ultimately
determine the impact this has on re-epithelialization of
acute burn wounds. This is the first RCT in the area of
acute burn injuries which examines the relationships
among pain, stress, anxiety and re-epithelialization.
The rate of re-epithelialization has discernible implica-
tions for the formation of hypertrophic scarring and the
long term physical and psychological issues resulting
from scarring. The significance of this study is that if the
Ditto™ intervention is associated with a reduction in
time taken for acute burn wounds to re-epithelialize,
patients may heal within the optimal 10 to 14 days, re-
ducing the likelihood of hypertrophic scarring [62].
This trial will also be the first to measure the utility of
salivary cortisol and salivary α-amylase as indicators of
stress during acute burn wound care procedures. Data
collected in the course of this study will seek to answer
many questions regarding the pain and stress experi-
enced by burned children, including: do children’s stress
and pain levels predict re-epithelialization rate?; are pain
and stress levels positively correlated?; and is there an
association with age or gender?
There are some limitations with this study, mostly
related to dealing with children in pain. There may be
challenges with obtaining laser Doppler image (LDI)
scans to determine burn wound depth. During scans
children are required to remain very still for up to sev-
eral minutes, ideally with their wounds free of dressings;
however, exposing wounds to air flow can cause
increased pain for the patient. The Visitrak™ measure
involves tracing wounds, which may also be challenging
for children not wanting their burns to be touched. The
individualized perception of pain poses an additional
limitation to measuring Ditto™ effectiveness. Exposure to
noxious stimuli as an infant has the potential to perman-
ently change the neuronal architecture of the developing
brain, thus resulting in greater pain sensitivity as adoles-
cents [63]. This study will include children with varying
experiences and memories of pain, which will shape
their experience of and rating of pain levels regardless of
Ditto™ engagement. To attempt to diminish this effect,
children known to have existing psychological issues, or
known to SCAN or child safety are excluded from this
study.The diurnal variation of cortisol may create challenges
in the analysis of salivary cortisol. The cortisol awaken-
ing peak occurs an hour after waking, and burn clinics
occur early in the morning, so when study samples are
taken it will be more difficult to identify any peaks in
stress levels. Ideally, a within-subjects design is best
when comparing highly variable biological markers;
however, as procedural preparation is a strong compo-
nent of this proposed study, a within-subjects design is
not feasible.
Significance of the study
The pain associated with burn injuries and the need for
additional treatment to standard pharmacological man-
agement is widely known and well established in the lit-
erature. Limited staff resources and busy burn clinics are
common place, highlighting the need for interventions
such as the Ditto™ device, which require very little set-up
time. The effectiveness of the Ditto™ device in reducing
pain and time taken for burn wound care procedures is
well established [33,34]. The potential of this device to
also improve wound healing is of great significance in the
burns field, possibly leading to decreased risk of scarring
and scar management requirements and perhaps the dif-
ference between grafting and not grafting more severe
burns. Establishing a link between reduced pain, stress
and anxiety and improving healing time in acute burn
wounds would be of major significance for patients and
health care providers, and has application for all health
care procedures which require pain/stress management,
not just acute burns.
Trial status
This trial is currently continuing to recruit participants
and collect data. The cessation of participant recruit-
ment is planned for 31 August 2012 and data collection
is likely to continue to January 2013 (with data collection
continuing until three months post re-epithelialization of
participant’s burns).
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